Pertuzumab: increasing the options.
Citation: Oncology (Williston Park). 28(3):199, 204, 210, 2014 Mar.PMID: 24855727Institution: Washington Cancer InstituteForm of publication: Journal ArticleMedline article type(s): Comment | Journal Article | Research Support, Non-U.S. Gov'tSubject headings: *Antibodies, Monoclonal, Humanized/tu [Therapeutic Use] | *Antineoplastic Agents/tu [Therapeutic Use] | *Breast Neoplasms/dt [Drug Therapy] | *Drug Approval | *Receptor, erbB-2/ai [Antagonists & Inhibitors] | Animals | Female | HumansLocal holdings: Available online from MWHC library: 1995 - present, Available in print through MWHC library: 1999 - presentISSN:- 0890-9091
| Item type | Current library | Collection | Call number | Status | Date due | Barcode |
|---|---|---|---|---|---|---|
| Journal Article | MedStar Authors Catalog | Article | Available | 24855727 |
Available online from MWHC library: 1995 - present, Available in print through MWHC library: 1999 - present
English